Skip to main content

Day: November 15, 2019

PURA – Puration Confirms Closing Acquisition To Bottle CBD Beverages In Europe

DALLAS, Nov. 15, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE — Puration, Inc. (USOTC: PURA) today confirmed finalizing the acquisition of a German company that will enable PURA to bottle its CBD beverages locally for distribution throughout the European market. PURA announced the closing of the acquisition yesterday. The acquisition was driven by PURA recently signing a distribution agreement in Europe for its EVERx CBD Sports Water with other CBD infused beverages to follow. The initial European distribution agreement is estimated to add $4 million in sales next year. Management indicates that the potential of European distribution beyond the initial $4 million projection warrants the establishment of a local bottling capacity. The European market for CBD is projected to reach nearly US $17 billion by 2023. The bottling expansion...

Continue reading

Crown Point to Proceed with Return of Capital

CALGARY, Alberta, Nov. 15, 2019 (GLOBE NEWSWIRE) — Crown Point Energy Inc. (“Crown Point” or the “Company”) is pleased to announce that its board of directors has determined to proceed with the previously announced special distribution to the holders (the “Shareholders“) of the Company’s common shares (the “Shares“).Crown Point will reduce the stated capital of its Shares by US$0.185 per Share to permit the Company to pay a special distribution to Shareholders in the amount of US$0.185 per Share, for a total special distribution of approximately US$13.5 million (collectively, the “Return of Capital“). The Company currently anticipates that the Return of Capital will be paid in December 2019, however the record date, ex-distribution date and payment date for the Return of Capital will be...

Continue reading

TKK Symphony Acquisition Corporation Announces Extension of Expiration Date of Tender Offer for its Ordinary Shares

Beijing, Nov. 15, 2019 (GLOBE NEWSWIRE) — TKK Symphony Acquisition Corporation (“TKK” or the “Company”) today announced that it has extended the expiration date of its previously announced tender offer to purchase up to 25,000,000 ordinary shares at a purchase price of $10.26 per share in cash. The offer is being made in connection with the Company’s previously announced merger with Glory Star New Media Group Limited, a Cayman Islands exempted company. As amended, the tender offer will now expire at 5:00 p.m. New York City time, on Monday, December 2, 2019, unless further extended or earlier terminated.Continental Stock Transfer & Trust Company, the depositary for the tender offer, has advised TKK that, as of 11:00 a.m., New York City time, on Friday, November 15, 2019, an aggregate of 12,210,031 ordinary shares were properly...

Continue reading

Arctic Glacier Issues Default Status Report Pursuant to National Policy 12-203

WINNIPEG, Nov. 15, 2019 (GLOBE NEWSWIRE) — Arctic Glacier Income Fund (CSE: AG.UN) (the “Fund”) is providing a default status report, in accordance with the alternative information guidelines set out in National Policy 12-203 Cease Trade Orders for Continuous Disclosure Defaults (“National Policy 12-203”).On August 15, 2012, the Fund announced (the “Default Announcement”) that it would not be able to file an interim financial report and interim management’s discussion and analysis for the period ended June 30, 2012, together with the related certification of filings under National Instrument 52-109 Certification of Disclosure in Issuers’ Annual and Interim Filings (collectively, the “Continuous Disclosure Documents”) by August 29, 2012, the deadline prescribed by securities legislation (the “Specified Requirement”).Except as...

Continue reading

SCWorx Announces Third Quarter 2019 Revenue Increased 74% over Third Quarter 2018

NEW YORK, Nov. 15, 2019 (GLOBE NEWSWIRE) — SCWorx Corp. (Nasdaq: WORX) (“SCWorx” or the “company”) announced today its financial results for the third quarter ended September 30, 2019.  “We continue to execute on our core business goals, reaching double-digit revenue growth driven by the addition of new customer contracts,” said Marc Schessel, CEO of SCWorx. “Our SaaS business model delivers three to five-year contracts, which provide revenue growth, stability, and tremendous visibility into our backlog and future revenue opportunities. It is our expectation that our team will continue to add new revenue each quarter due to our Ultraverse Platform™, which we believe to be one of the most robust data management platforms in the vast healthcare provider (hospital) marketplace.“In addition to the growth that we have experienced with...

Continue reading

Diffusion Pharmaceuticals Announces Closing of $4.0 Million Public Offering

CHARLOTTESVILLE, Va., Nov. 15, 2019 (GLOBE NEWSWIRE) — Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) (“Diffusion,” the “Company,” “we,” “our” or “us”) a clinical-stage biotechnology company developing new treatments for life-threatening medical conditions by improving the body’s ability to bring oxygen to the areas where it is needed most, today announced the closing of its previously announced public offering of an aggregate of 11,428,572 shares of common stock (or common stock equivalents) of the Company, together with accompanying common warrants, at a public offering price of $0.35 per share and associated warrants. Each share of common stock (or common stock equivalent) sold in the offering was sold collectively with (i) a common warrant to purchase one share of common stock expiring eighteen months from the date of issuance...

Continue reading

Nexstim Plc: In total 15,687,350 shares subscribed in the directed share issue

Company announcement, Inside information, Helsinki, 15 November at 6.30 pm (EET)Nexstim Plc: In total 15,687,350 shares subscribed in the directed share issueBased on a resolution of the Board of Directors of Nexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or the “Company”) announced on 11 November 2019, 15,687,350 new shares were subscribed for. Upon approval of such subscriptions today, the Company will receive approximately EUR 1.8 million in proceeds for such directed issue excluding underwriting fees as well as other fees and expenses.As announced on 21 October 2019, 6 November 2019 and 11 November 2019 by the Company, Offer Warrants issued in spring 2019 have been exercised for share subscriptions and the Company has arranged a directed share issue. The combined gross proceeds of the exercise of the Offer Warrants...

Continue reading

Nexstim Oyj: Suunnatussa osakeannissa merkittiin yhteensä 15 687 350 osaketta

Yhtiötiedote, Sisäpiiritieto, Helsinki, 15.11.2019, klo 18.30Nexstim Oyj: Suunnatussa osakeannissa merkittiin yhteensä 15 687 350 osaketta11.11.2019 tiedotetun Nexstim Oyj:n (NXTMH:HEX, NXTMS:STO) (”Nexstim” tai ”Yhtiö”) hallituksen päätöksen nojalla merkittiin 15 687 350 uutta osaketta. Merkintöjen hyväksyntien tapahduttua tänään Yhtiön odotetaan saavan suunnatusta osakeannista noin 1,8 miljoonan euron tuotot ennen merkintätakauspalkkioita sekä muita palkkioita ja kuluja.Keväällä 2019 liikkeeseelasketut Antioikeudet on käytetty osakkeiden merkintään ja Yhtiö on järjestänyt suunnatun osakeannin, kuten on tiedotettu 21.10.2019, 6.11.2019 ja 11.11.2019. Yhtiö on saanut Antioikeuksien osakemerkinnöistä ja suunnatusta osakeannista yhteenlasketut noin 2,9 miljoonan euron bruttotuotot, ja noin 2,7 miljoonan euron nettotuotot palkkioiden ja...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.